Literature DB >> 23518860

Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography.

Kenji Goto1, Hideo Takebayashi, Yasuki Kihara, Arata Hagikura, Yasukazu Fujiwara, Yuetsu Kikuta, Katsumasa Sato, Sunao Kodama, Masahito Taniguchi, Shigeki Hiramatsu, Seiichi Haruta.   

Abstract

AIMS: The features of neointima after bare metal stent (BMS) or drug-eluting stent (DES) implantation have not yet been fully characterised. The aim of this study was to investigate in-stent neointima characteristics according to stent type and restenotic phase. METHODS AND
RESULTS: The study included 59 consecutive patients undergoing target lesion revascularisation for in-stent restenosis (ISR) evaluated by optical coherence tomography (OCT) during the early phase (≤1 year, n=30) and late phase (>1 year, n=29) after either BMS (n=37) or DES (n=22) implantation. The OCT signal patterns of tissues at the minimal lumen area were categorised into three patterns: (1) homogeneous high-signal band, (2) heterogeneous mixed-signal band, and (3) lipid-laden intima. The predominant OCT pattern was homogeneous high-signal band in the BMS early phase (19/21 [91%]), lipid-laden intima in the BMS late phase (12/16 [76%]), and heterogeneous mixed-signal band in the DES late phase (9/13 [69%]). Heterogeneous mixed-signal band was seen more frequently in the DES early phase compared with BMS early phase (44% vs. 9%, p<0.05).
CONCLUSIONS: There were differences of neointima according to stent type and restenotic phase, and this may lead to a better understanding of the different mechanisms of ISR.

Entities:  

Mesh:

Year:  2013        PMID: 23518860     DOI: 10.4244/EIJV9I5A96

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  7 in total

1.  Mechanism of in-stent restenosis after second-generation drug-eluting stents (DES): is it different from bare-metal stents and first-generation DES?

Authors:  Shoichi Kuramitsu; Shinichi Shirai; Kenji Ando
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.

Authors:  Mahmoud Sabbah; Kazushige Kadota; Azza El-Eraky; Hanan M Kamal; Ahmed-Tageldien Abdellah; Ahmed El Hawary
Journal:  Int J Cardiovasc Imaging       Date:  2017-04-25       Impact factor: 2.357

3.  In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.

Authors:  Takashi Kajiya; Hiroshi Yamaguchi; Junichiro Takaoka; Kengo Fukunaga; Ryoichi Arima; Akihiro Miyamura; Toshiko Ninomiya; Nobuhiko Atsuchi; Yoshihiko Atsuchi; Mitsuyasu Terashima; Hideaki Kaneda; Mitsuru Ohishi
Journal:  Singapore Med J       Date:  2018-04-10       Impact factor: 1.858

4.  Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis.

Authors:  Erion Xhepa; Robert A Byrne; Fernando Rivero; Andi Rroku; Javier Cuesta; Gjin Ndrepepa; Sebastian Kufner; Teresa Bastante Valiente; Salvatore Cassese; Marcos Garcia-Guimaraes; Anna Lena Lahmann; Himanshu Rai; Heribert Schunkert; Michael Joner; María José Pérez-Vizcayno; Nieves Gonzalo; Fernando Alfonso; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2019-02-19       Impact factor: 5.460

5.  A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data.

Authors:  Seung Hun Lee; Jae Young Cho; Je Sang Kim; Hyun Jong Lee; Jeong Hoon Yang; Jae Hyoung Park; Soon Jun Hong; Rak Kyeong Choi; Seung-Hyuk Choi; Hyeon-Cheol Gwon; Do-Sun Lim; Cheol Woong Yu
Journal:  Clin Res Cardiol       Date:  2019-09-24       Impact factor: 5.460

6.  Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents.

Authors:  Kadriye Kilickesmez; Gianni Dall'Ara; Juan Carlos Rama-Merchan; Matteo Ghione; Alessio Mattesini; Carlos Moreno Vinues; Nikolaos Konstantinidis; Michele Pighi; Rodrigo Estevez-Loureiro; Carlo Zivelonghi; Alistair C Lindsay; Gioel G Secco; Nicolas Foin; Ranil De Silva; Carlo Di Mario
Journal:  Int J Cardiol Heart Vessel       Date:  2014-03-19

7.  Novel Polymer-Free Everolimus-Eluting Stent Fabricated using Femtosecond Laser Improves Re-endothelialization and Anti-inflammation.

Authors:  In-Ho Bae; Myung Ho Jeong; Kyung Seob Lim; Dae Sung Park; Jae Won Shim; Jun-Kyu Park; Kwang Hwan Oh; Mi Rim Jin; Doo Sun Sim
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.